Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000309483 is an annotated novel transcript on the antisense strand relative to the ALDH3B2 locus. "Antisense" means this RNA is transcribed from the DNA strand opposite to the protein-coding ALDH3B2 gene. Most such transcripts are non-coding RNAs—often predicted from sequencing data with no known protein product, function, or drug targeting relevance. There is no evidence that this particular transcript encodes a functional protein or is involved in known pathways, biological functions, or diseases. It is not recognized as a therapeutic target, receptor, enzyme, transporter, or similar actionable molecule. The phrase "novel transcript" indicates incompletely characterized non-coding RNA elements or computational predictions, rather than established gene products. \nThis is not a standard, actionable target; its entry is most likely included due to automated genome annotation and does not represent a characterized molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to ALDH3B2.